FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Bayer Healthcare Bronkaid Dual Action Formula Recall

Bronkaid Dual Action Formula, Ephedrine Sulfate 25 mg/Bronchodilator, Guaifenesin 400 m…

Bayer Healthcare, LLC · Morristown, NJ

Risk level
Class III
Reported by FDA
Mar 6, 2013
Recall ID
D-177-2013
Check your lot numberHow we source this data

Summary

Bayer Healthcare recalled Bronkaid Dual Action Formula starting Dec 7, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-177-2013 on Mar 6, 2013. Reason: Labeling: Label lacks warning or Rx legend; Certain information was inadvertently excluded from the product carton label. Status: Terminated.

Why it was recalled

Labeling: Label lacks warning or Rx legend; Certain information was inadvertently excluded from the product carton label.

Product description

Bronkaid Dual Action Formula, Ephedrine Sulfate 25 mg/Bronchodilator, Guaifenesin 400 mg/Expectorant, a) 24 coated caplets per blister pack, UPC 300240537879, b) 60 coated caplets per blister pack, UPC 300240537855, Bayer HealthCare LLC, Consumer Care, P.O. Box 1910, Morristown, NJ, 07962.

Lot numbers, UPCs & expiration codes

Lot #s: a) NAA0B3T, NAA0BDB, NAA0B3P, NAA0B3R, NAA0B3N, NAA070E, NAA070F, NAA03PX, NAA03B5, NAA03B6, NAA02LT. b) NAA0TF3, NAA0TF2, NAA0TF0, NAA0TF1, NAA0TET, NAA0TEW, NAA0TEX, NAA0HHL, NAA0HHK, NAA0HHN, NAA0HHH, NAA0DK5, NAA0DK4, NAA0DK3, NAA0CHE, NAA0CHD, NAA0B3L, NAA0B3K, NAA09XE, NAA09XB, NAA07H2, NAA09XD, NAA07H1, NAA09XA, NAA09XC, NAA07H3, NAA07H4, NAA05BB, NAA05BA, NAA07H0, NAA070D, NAA070C, NAA03PW, NAA05B9, NAA070B, NAA03B8, NAA03B7, NAA02N1, NAA02LW, 244511P, 244501P, 244481P, 244471P, 244491P, 244451P.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-177-2013
Classification
Class III
Status
Terminated
Recall initiated
Dec 7, 2012
FDA report date
Mar 6, 2013
Quantity
1,353,420 Blister Packs
Recall type
Voluntary: Firm initiated
Recalling firm
Bayer Healthcare, LLC

Original FDA data

Every field from FDA enforcement report D-177-2013, exactly as published.

Show all FDA fields
City
Morristown
State
NJ
Status
Terminated
Country
United States
Event ID
63821
Address
36 Columbia Rd
Code information
Lot #s: a) NAA0B3T, NAA0BDB, NAA0B3P, NAA0B3R, NAA0B3N, NAA070E, NAA070F, NAA03PX, NAA03B5, NAA03B6, NAA02LT. b) NAA0TF3, NAA0TF2, NAA0TF0, NAA0TF1, NAA0TET, NAA0TEW, NAA0TEX, NAA0HHL, NAA0HHK, NAA0HHN, NAA0HHH, NAA0DK5, NAA0DK4, NAA0DK3, NAA0CHE, NAA0CHD, NAA0B3L, NAA0B3K, NAA09XE, NAA09XB, NAA07H2, NAA09XD, NAA07H1, NAA09XA, NAA09XC, NAA07H3, NAA07H4, NAA05BB, NAA05BA, NAA07H0, NAA070D, NAA070C, NAA03PW, NAA05B9, NAA070B, NAA03B8, NAA03B7, NAA02N1, NAA02LW, 244511P, 244501P, 244481P, 244471P, 244491P, 244451P.
Postal code
07960-4526
Report date
Mar 6, 2013
Product type
Drugs
Recall number
D-177-2013
Classification
Class III
Recalling firm
Bayer Healthcare, LLC
Product quantity
1,353,420 Blister Packs
Termination date
Apr 1, 2014
Reason for recall
Labeling: Label lacks warning or Rx legend; Certain information was inadvertently excluded from the product carton label.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bronkaid Dual Action Formula, Ephedrine Sulfate 25 mg/Bronchodilator, Guaifenesin 400 mg/Expectorant, a) 24 coated caplets per blister pack, UPC 300240537879, b) 60 coated caplets per blister pack, UPC 300240537855, Bayer HealthCare LLC, Consumer Care, P.O. Box 1910, Morristown, NJ, 07962.
Distribution pattern
Nationwide
Recall initiation date
Dec 7, 2012
Initial firm notification
Letter
Center classification date
Feb 28, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-177-2013, published Mar 6, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls